| Cholera epidemic in Yemen, 2016–18: an analysis of surveillance data A Camacho, M Bouhenia, R Alyusfi, A Alkohlani, MAM Naji, ... The Lancet Global Health 6 (6), e680-e690, 2018 | 199 | 2018 |
| Packed with Salmonella—Investigation of an International Outbreak of Salmonella Senftenberg Infection Linked to Contamination of Prepacked Basil in 2007 L Pezzoli, R Elson, CL Little, H Yip, I Fisher, R Yishai, E Anis, L Valinsky, ... Foodborne pathogens and disease 5 (5), 661-668, 2008 | 143 | 2008 |
| Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis Q Bi, E Ferreras, L Pezzoli, D Legros, LC Ivers, K Date, F Qadri, L Digilio, ... The Lancet Infectious Diseases 17 (10), 1080-1088, 2017 | 139 | 2017 |
| Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study AS Azman, LA Parker, J Rumunu, F Tadesse, F Grandesso, LL Deng, ... The Lancet Global Health 4 (11), e856-e863, 2016 | 127 | 2016 |
| Randomized, placebo-controlled, double-blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B-cell lymphoma L Marconato, P Frayssinet, N Rouquet, S Comazzi, VF Leone, P Laganga, ... Clinical Cancer Research 20 (3), 668-677, 2014 | 89 | 2014 |
| International outbreak of Salmonella Senftenberg in 2007 L Pezzoli, R Elson, C Little, I Fisher, H Yip, TM Peters, M Hampton, ... Weekly releases (1997–2007) 12 (24), 3218, 2007 | 63 | 2007 |
| A second affordable oral cholera vaccine: implications for the global vaccine stockpile SN Desai, L Pezzoli, S Martin, A Costa, C Rodriguez, D Legros, W Perea The Lancet Global Health 4 (4), e223-e224, 2016 | 57 | 2016 |
| Global oral cholera vaccine use, 2013–2018 L Pezzoli Vaccine 38, A132-A140, 2020 | 56 | 2020 |
| Single-dose cholera vaccine in response to an outbreak in Zambia E Ferreras, E Chizema-Kawesha, A Blake, O Chewe, J Mwaba, G Zulu, ... New England Journal of Medicine 378 (6), 577-579, 2018 | 56 | 2018 |
| Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: a prospective controlled study M Pezzoli, M Magnano, L Maffi, L Pezzoli, P Marcato, M Orione, D Cupi, ... European Archives of Oto-Rhino-Laryngology 272 (7), 1659-1666, 2015 | 53 | 2015 |
| Routine childhood vaccination programme coverage, El Salvador, 2011—In search of timeliness E Suárez-Castaneda, L Pezzoli, M Elas, R Baltrons, EO Crespin-Elías, ... Vaccine 32 (4), 437-444, 2014 | 50 | 2014 |
| Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010 CR Ouandaogo, TM Yaméogo, FVK Diomandé, C Sawadogo, ... Vaccine 30, B46-B51, 2012 | 44 | 2012 |
| Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era SN Desai, L Pezzoli, KP Alberti, S Martin, A Costa, W Perea, D Legros Human vaccines & immunotherapeutics 13 (3), 579-587, 2017 | 39 | 2017 |
| Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia M Poncin, G Zulu, C Voute, E Ferreras, CM Muleya, K Malama, L Pezzoli, ... Bulletin of the World Health Organization 96 (2), 86, 2018 | 37 | 2018 |
| Oral Cholera Vaccine Working Group of The Global Task Force on Cholera Control. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and … Q Bi, E Ferreras, L Pezzoli, D Legros, LC Ivers, K Date, F Qadri, L Digilio, ... Lancet Infect Dis 17 (10), 1080-8, 2017 | 36 | 2017 |
| The multi-sectorial emergency response to a cholera outbreak in internally displaced persons camps in Borno state, Nigeria, 2017 MC Ngwa, A Wondimagegnehu, I Okudo, C Owili, U Ugochukwu, ... BMJ Global Health 5 (1), e002000, 2020 | 35 | 2020 |
| Cluster‐sample surveys and lot quality assurance sampling to evaluate yellow fever immunisation coverage following a national campaign, Bolivia, 2007 L Pezzoli, S Pineda, P Halkyer, G Crespo, N Andrews, O Ronveaux Tropical Medicine & International Health 14 (3), 355-361, 2009 | 29 | 2009 |
| Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi KP Msyamboza, H Hausi, A Chijuwa, V Nkukumila, HW Kubwalo, J Im, ... Pan African Medical Journal 23 (1), 2016 | 28 | 2016 |
| Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010 SH Kim, L Pezzoli, H Yacouba, T Coulibaly, MH Djingarey, WA Perea, ... PloS one 7 (1), e29116, 2012 | 28 | 2012 |
| Clustered lot quality assurance sampling: a pragmatic tool for timely assessment of vaccination coverage K Greenland, M Rondy, A Chevez, N Sadozai, A Gasasira, EA Abanida, ... Tropical medicine & international health 16 (7), 863-868, 2011 | 28 | 2011 |
Andrew S. AzmanJohns Hopkins University; Médecins sans Frontières; Hôpitaux universitaires de GenèveVerified email at jhu.edu
